Dr. Robert K. Schultz, Ph.D. has more than 35 years of experience in Pharmaceutical and Medical Device development. Currently, he is President and Chief Executive Officer of Sollievo Pharmaceuticals, Inc., a start-up company focused on improving the performance of off-patent drugs to meet the medical needs not currently addressed by the original dosage forms. Dr. Schultz served as President and Chief Operating Officer of REVA Medical, Inc., a San Diego based medical device company. Dr. Schultz obtained his PhD. in Pharmaceutics and his B.S. in Pharmacy from the University of Minnesota. He has served as an Adjunct Assistant Professor of Industrial Pharmacy and was a member of the College of Pharmacy Board of Advisors, as well as, several Technology Assessment Committees for the University. Dr. Robert K. Schultz is an opinion columnist for the CEOWORLD magazine. Follow him on LinkedIn.